(Q36958269)

17 August 2017

1 reference

title

Oxidative stress and cerebrovascular dysfunction in mouse models of Alzheimer's disease (English)

1 reference

17 August 2017

0 references

Hamel E

1

1 reference

17 August 2017

Nicolakakis N

2

1 reference

17 August 2017

Aboulkassim T

3

1 reference

17 August 2017

Ongali B

4

1 reference

17 August 2017

Tong XK

5

1 reference

17 August 2017

language of work or name

1 reference

2 October 2007

1 reference

17 August 2017

published in

Experimental Physiology

1 reference

17 August 2017

volume

93

1 reference

17 August 2017

issue

1

1 reference

17 August 2017

page(s)

116-120

1 reference

Selective cholinergic denervation, independent from oxidative stress, in a mouse model of Alzheimer's disease

17 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038729

Neurovascular unit dysfunction: a vascular component of Alzheimer disease?

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038729

Is Alzheimer's disease preceded by neurodegeneration or cerebral hypoperfusion?

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038729

Reduced brain tissue perfusion in TGF-beta 1 transgenic mice showing Alzheimer's disease-like cerebrovascular abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038729

Pioglitazone does not increase cerebral glucose utilisation in a murine model of Alzheimer's disease and decreases it in wild-type mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038729

Cerebrovascular transforming growth factor-beta contributes to inflammation in the Alzheimer's disease brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038729

Cholinergic modulation of the cortical microvascular bed.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038729

Neurovascular regulation in the normal brain and in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038729

Cerebrovascular degeneration is related to amyloid-beta protein deposition in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038729

Alterations in cerebral blood flow and glucose utilization in mice overexpressing the amyloid precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038729

Cerebrovascular autoregulation is profoundly impaired in mice overexpressing amyloid precursor protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038729

Neuronal depletion of calcium-dependent proteins in the dentate gyrus is tightly linked to Alzheimer's disease-related cognitive deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038729

Abeta-induced vascular oxidative stress and attenuation of functional hyperemia in mouse somatosensory cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038729

NADPH-oxidase-derived reactive oxygen species mediate the cerebrovascular dysfunction induced by the amyloid beta peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038729

Vascular abnormalities: the insidious pathogenesis of Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038729

Regional cholinergic denervation of cortical microvessels and nitric oxide synthase-containing neurons in Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038729

Vascular remodeling versus amyloid beta-induced oxidative stress in the cerebrovascular dysfunctions associated with Alzheimer's disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038729

Microvasculature in brain biopsy specimens from patients with Alzheimer's disease: an immunohistochemical and ultrastructural study

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038729

Chronic overproduction of transforming growth factor-beta1 by astrocytes promotes Alzheimer's disease-like microvascular degeneration in transgenic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038729

Association of a polymorphism of the transforming growth factor-beta1 gene with blood pressure in Japanese individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038729

Vascular basement membrane pathology and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038729

Neurovascular mechanisms of Alzheimer's neurodegeneration

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038729

Transforming growth factor-beta 1 impairs endothelin-1-mediated contraction of brain vessels by inducing mitogen-activated protein (MAP) kinase phosphatase-1 and inhibiting p38 MAP kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038729

Pathological alterations of the cerebral microvasculature in Alzheimer's disease and related dementing disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1113%2FEXPPHYSIOL.2007.038729

10.1113/EXPPHYSIOL.2007.038729

21 January 2018

Identifiers

DOI

1 reference

17 August 2017

1 reference